Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 35 min ago
Peer-reviewedLicence not statedNanomedicine

Evolving skin cancer therapeutics: molecular and genetic drivers, immunotherapy challenges, and advances in nanogel-based nanomedicine

  • Sabah Aafreen1
  • Sayed Abdur Rehman1
  • Tahmeed Parvez Barbhuiya1
  • Waleed Y. Rizg2
  • Majed A. Alghamdi2
  • Shadab Md2
  • Ashif Iqubal3
  • Mohammad Kashif Iqubal4
4 affiliations
  1. 1School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi, India
  2. 2Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
  3. 3Medical Advisor, Pfizer India Pvt Limited, New Delhi, India
  4. 4Irma Lerma Rangel College of Pharmacy, Texas A & M Health Science Center, Texas A&M University, College Station, TX, USA
Read full textDOICite

Related

  1. The evolving landscape of fungal keratitis: from emerging pathogens to precision diagnostics and novel therapeutics
    Sourav Das, Mansi Jain, Agimanailiu Khapuinamai +1
    Future MicrobiologyPeer-reviewedLicence not statedFull textGeneral medicinePMC
  2. A Narrative Review of Nanomedicine in Cancer Therapy: Modulating Metabolic Reprogramming to Enhance Immunotherapy.
    Hongpeng Wu, Fengyi Wang, Wei Sun +1
    International journal of nanomedicinePeer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  3. Editorial: Evolving non-invasive biomarkers: chemokines and multi-omic profiling in NSCLC immunotherapy response
    Jacobo Rogado, Elisabet González del Portillo, Diego Casado Elía +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  4. Opportunities and challenges in the development of evolving EGFR inhibitors to overcome EGFR TKIs resistance
    Yi Chen, Qiu-pei Liu, Si-jie Yang +3
    Acta Pharmacologica SinicaPeer-reviewedLicence not statedFull text1 citedGeneral medicinePMC
  5. Antibody peptide conjugates as multifunctional therapeutics: Mechanisms, challenges, and prospects.
    Fei Xie, Lianqi Liu, Qi Cheng +3
    Acta pharmaceutica Sinica. BPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{aafreen2026evolving,
  title = {{Evolving skin cancer therapeutics: molecular and genetic drivers, immunotherapy challenges, and advances in nanogel-based nanomedicine}},
  author = {Sabah Aafreen and Sayed Abdur Rehman and Tahmeed Parvez Barbhuiya and Waleed Y. Rizg and Majed A. Alghamdi and Shadab Md and Ashif Iqubal and Mohammad Kashif Iqubal},
  journal = {Nanomedicine},
  year = {2026},
  month = oct,
  doi = {10.1080/17435889.2026.2742412},
  url = {https://doi.org/10.1080/17435889.2026.2742412},
}
RIS
TY  - JOUR
TI  - Evolving skin cancer therapeutics: molecular and genetic drivers, immunotherapy challenges, and advances in nanogel-based nanomedicine
AU  - Sabah Aafreen
AU  - Sayed Abdur Rehman
AU  - Tahmeed Parvez Barbhuiya
AU  - Waleed Y. Rizg
AU  - Majed A. Alghamdi
AU  - Shadab Md
AU  - Ashif Iqubal
AU  - Mohammad Kashif Iqubal
PY  - 2026
DA  - 2026/10/06
JO  - Nanomedicine
DO  - 10.1080/17435889.2026.2742412
UR  - https://doi.org/10.1080/17435889.2026.2742412
SN  - 1743-5889
SN  - 1748-6963
ER  -